Key Advantages of Samsung Biologics Manufacturing Services
Seamless CGMP Manufacturing & Fill-Finish
Dedicated Project Management for Complex Molecules
-
Drug Substance Manufacturing
- Leveraging economies of scale and fast turnaround, our drug substance manufacturing ensures consistent, high-quality biologics at both clinical and commercial scales.
-
Drug Product & Aseptic Fill-Finish Services
- Our drug product manufacturing includes aseptic fill-finish services designed to ensure patient safety, product integrity, and regulatory compliance across clinical and commercial stages.
Why Choose Samsung Biologics as Your CDMO Partner
- Total capacity in 2025
- 784 kL
-
BIO Campus I
604 kL
+
-
Plant 5
180 kL
BIO Campus I
- Total Capacity
- 604,000 L
- Plant 1
- 30,000 L
- Plant 2
- 154,000 L
- Plant 3
- 180,000 L
- Plant 4
- 240,000 L
- Plant 5
- 180,000 L
- Plant 6-8
- 540,000 L*
BIO Campus II
- Plant 5-8
- 720,000 L*
-
-
Consecutive years
to be recognized by the
CDMO Leadership Awards
-
- 0
-
Regulatory approvals
(FDA, EMA, PMDA, etc.)
Related Content